Promoter CpG hypermethylation and downregulation of DICE1 expression in prostate cancer
✍ Scribed by Röpke, Albrecht; Buhtz, Peter; Böhm, Malte; Seger, Jeannette; Wieland, Ilse; Allhoff, Ernst P; Wieacker, Peter F
- Book ID
- 110069867
- Publisher
- Nature Publishing Group
- Year
- 2005
- Tongue
- English
- Weight
- 301 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0950-9232
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Promoter hypermethylation of circulating cell DNA has been advocated as a diagnostic marker for prostate cancer, but its prognostic use is currently unclear. To assess this role, we compared hypermethylation of circulating cell DNA from prostate cancer patients with (Group 1, __n__ = 20
## Abstract Several studies have shown that E‐cadherin expression is lost during malignant transformation. We hypothesized that CpG methylation in the promoter region may inactivate the expression of the E‐cadherin gene in human bladder cancer. Normal and bladder cancer samples from 51 patients wer
## Abstract The incidence and mortality of prostate cancer (PC) is approximately 2‐fold higher among African‐Americans as compared to Caucasians and very low in Asian. We hypothesize that inactivation of __GSTP1__ genes through CpG methylation plays a role in the pathogenesis of PC, and its ability